Seasonal affective disorder, winter type:current insights and treatment options

Ybe Meesters,1 Marijke CM Gordijn,2,3 1University Center for Psychiatry, University Medical Center Groningen, 2Department of Chronobiology, GeLifes, University of Groningen, Groningen, the Netherlands; 3Chrono@Work B.V., Groningen, the Netherlands Abstract: Seasonal affective disorder (SAD), winter type, is a seasonal pattern of recurrent major depressive episodes most commonly occurring in autumn or winter and remitting in spring/summer. The syndrome has been well-known for more than three decades, with light treatment being the treatment of first choice. In this paper, an overview is presented of the present insights in SAD. Description of the syndrome, etiology, and treatment options are mentioned. Apart from light treatment, medication and psychotherapy are other treatment options. The predictable, repetitive nature of the syndrome makes it possible to discuss preventive treatment options. Furthermore, critical views on the concept of SAD as a distinct diagnosis are discussed. Keywords: seasonal affective disorder, review, light treatment, medication, psychotherapy, preventio

Exploring the Impact of Commercial Wearable Activity Trackers on Body Awareness and Body Representations: A Mixed-Methods Study on Self-tracking

Wearable trackers are believed to enhance users’ self-knowledge, but their impact on the relationship that people have with their own bodies is relatively unexplored. This study aims to shed light on the potential of physiological data collected by a commercial wearable activity tracker to influence how users relate with their own bodies, specifically their body awareness, body image, body consciousness, and body surveillance. Additionally, the study seeks to determine whether this change in body perception improves or worsens the users’ relation with their own bodies. We recruited 321 first-time wearable users, including a control group. Participants in the experimental group (N = 225) completed a set of scales and questionnaires addressing body awareness and representations before and after wearing a Fitbit for four months, and 20 of them were further interviewed about their experience. The findings indicate that participants’ overall view of their bodies was not influenced by the device. However, the Fitbit did increase the awareness of bodily sensations, particularly for women. Moreover, we describe how participants made sense of the data displayed by the Fitbit, which was also used as an emotion-regulation tool. These results can contribute to the understanding of the impact of self-tracking technologies on the users’ perceptions of their own body and provide insights for future research in this field

The effect of bright light on rest-activity rhythms and behavioural and psychological symptoms of dementia

De fleste som lever med demens har også atferdsmessige- og psykologiske symptomer ved demens (APSD) som for eksempel depresjon, angst, agitasjon, og søvnforstyrrelser. APSD påvirker livskvalitet og pleiebehov. Aktivitetsrytmen er ofte endret hos personer med demens. For eksempel kan søvn og våkenhet forekomme uregelmessig, med rastløshet og atferdsforstyrrelser på kvelds- og nattestid, og søvn på dagtid. Forstyrrelser i søvn og våkenhet har negative konsekvenser for daglig fungering, kognisjon, og affekt. I tillegg er det trolig at denne typen problemer gjenspeiler forstyrrelse av den endogene cirkadiane rytmen. APSD, inkludert søvnproblemer, behandles ofte medikamentelt, på tross av at slik behandling har begrenset effekt og kan medføre alvorlige bivirkninger. Lys påvirker den cirkadiane rytmen, og kan i tillegg ha en innvirkning på våkenhet og humør. Disse omtales som ikke-visuelle effekter av lys. Lysterapi er en ikke-medikamentell behandling som ifølge noen tidligere studier kan ha en positiv effekt på affekt, agitasjon, søvnforstyrrelser og aktivitetsrytmer hos personer med demens, men resultatene fra ulike studier har ikke vært entydige. Målet med denne avhandlingen var å undersøke effekten av lysterapi på APSD og aktivitetsrytmer, gjennom en klynge-randomisert placebo-kontrollert studie over 24 uker – DEM.LIGHT studien. Et sekundært mål, og et forarbeid til hovedstudien, var å undersøke lysforholdene ved demensenheter på sykehjem. Artikkel 1 presenterte en undersøkelse av lys på 15 demensenheter i Bergen kommune, gjennomført ved to årstider og med lysmålinger i ulike retninger. Lysmålingene ble sammenlignet med grenseverdier basert på anbefalinger og tidligere forskning. Lysverdiene ble oppgitt i måleenheter som er relevante for ikkevisuelle effekter av lys. Artikkel 2 og 3 rapporterte resultater fra DEM.LIGHTstudien, gjennomført på 8 sykehjem med 69 deltagere. Intervensjonen besto av takmonterte LED-lys i fellesstuen på 4 demensenheter, som gav lys av ulik styrke og fargetemperatur gjennom dagen. Maksimalt nivå for intervensjonen var ~1000 lx og 6000 K, mellom kl. 10:00 og 15:00, målt vertikalt 1.2 m over gulvet. Kontrollgruppen (4 demensenheter) hadde standard innendørsbelysning (~150–300 lx, 3000 K). Data ble innhentet ved baseline, og etter 8, 16 og 24 uker. Artikkel 2 undersøkte effekten av lysbehandlingen på aktivitetsrytmer registrert med aktigrafi, og artikkel 3 undersøkte effekten på proxy-vurderte APSD-mål (Cornell Scale for Depression in Dementia, CSDD og Neuropsychiatric Inventory – Nursing Home Version, NPI-NH). Effekten av behandlingen ble analysert ved bruk av blandede regresjonsmodeller (multilevel models), med demensstadium (Functional Assessment Staging Tool, FAST skåre) ved baseline som en a priori bestemt kovariat. I tillegg ble baselineskårer på utfallsmålene inkludert som kovariater i analysene til artikkel 3. I artikkel 1 fant vi at de fleste målingene av lyset på demensenhetene var under terskelverdiene, uavhengig av årstid og måleretning. I artikkel 2 fant vi ingen forbedring av aktivitetsrytmen etter BLT hos personer med demens når vi korrigerte for multippel testing. Uten slik korreksjon var akrofasen (tidspunktet for aktivitetrytmens makspunkt) signifikant mindre forsinket (med en time) i uke 16 i intervensjonsgruppen sammenlignet med kontrollgruppen. Artikkel 3 rapporterte blandede resultater for effekten av lysintervensjonen på APSD. Det var en signifikant effekt på underskalaer som måler affektive symptomer i uke 16, men ikke i uke 8 eller 24, etter korreksjon for multippel testing. Det var en signifikant effekt på CSDD og NPI-NH total-skårer i uke 16 før, men ikke etter, korreksjon for multippel testing. Det var ingen signifikant effekt på andre underskalaer. Oppsummert peker funnene fra artikkel 1 mot at lyset på demensenheter er utilstrekkelig sett opp mot terskelverdier for ikke-visuelle effekter av lys. Likevel var resultatene fra DEM.LIGHT-studien, som økte belysningen på demensenheter, blandede. Basert på disse resultatene kan vi ikke anbefale takmontert lysterapi ved demensenheter. Det er imidlertid flere metodologiske utfordringer og karakteristikker ved utvalget som begrenser generaliserbarheten til disse funnene.Most people living with dementia have behavioural and psychological symptoms of dementia (BPSD), such as depression, anxiety, agitation, and disturbed sleep, that strongly affect well-being and care needs. The rest-activity rhythm (RAR), i.e., the diurnal pattern of activity, is often altered in individuals with dementia. Sleep and wakefulness may, for instance, occur at irregular intervals, characterised by restlessness and behavioural disturbances at night, and napping during the day. This disruption of the sleep-wake pattern is detrimental to functioning and well-being. It is also thought to reflect deterioration of the endogenous circadian rhythm. Pharmacotherapy is often used to treat BPSD, including sleep disturbances, but has limited efficacy and is associated with severe side effects. Light influences the circadian rhythm, and can also have effects on alertness and mood. These are collectively referred to as non-image forming (NIF) effects of light. Bright light treatment (BLT) is a non-pharmacological intervention that has been found to improve affective symptoms, agitation, sleep disorders, and RARs in people with dementia in some studies, but results have been mixed. The main aim of this thesis was to investigate the effect of BLT on RARs and BPSD in a 24-week cluster randomised controlled trial - the DEM.LIGHT trial (ClinicalTrials.gov identifier: NCT03357328). A secondary aim, and preparation for the trial, was to investigate the illumination in nursing home dementia units. Paper 1 was a field study investigating nursing home illumination in 15 dementia units across seasons and gaze directions. Measured illuminances were compared to thresholds suggested by industry standards and research, and measurement units relevant to NIF effects of light were used. Paper 2 and 3 reported results from the DEM.LIGHT trial, conducted at 8 dementia units, with 69 participants. In the intervention group (4 units), ceiling mounted LED-panels provided ambient light of varying illuminance and correlated colour temperature throughout the day, with a peak of ~1000 lx and 6000 K (measured vertically at 1.2 m) between 10:00 and 15:00. In the control group (4 units), standard indoor light of ~150–300 lx, 3000 K was used. Data were collected at baseline and at 8, 16, and 24 weeks. Paper 2 investigated the effect of the intervention on actigraphy-measured RARs, and paper 3 investigated the effect on proxy-rated BPSD measures: the Cornell Scale for Depression in Dementia (CSDD) and the Neuropsychiatric Inventory - Nursing Home Version (NPI-NH). Treatment effects were analysed using multilevel regression models, with dementia stage (score on the Functional Assessment Staging Tool, FAST) at baseline as a pre-determined covariate. In addition, baseline scores on the outcome measures were included as covariates in the models in paper 3. In paper 1 we found that, regardless of season and gaze direction, nearly all measured illuminances in dementia units fell below the thresholds. In paper 2, we found that there was no effect of BLT on RAR outcomes in people with dementia when controlling for multiple testing. Without controlling for multiple testing, the acrophase (i.e., timing of the activity peak) was significantly less delayed (by one hour) in the intervention group compared to the control group, in week 16. Paper 3 found mixed results for the effect of BLT on BPSD. There was a significant reduction of scores on affective subscales in the intervention group in week 16, but not at other follow-ups, after controlling for multiple testing. There was a significant effect on the NPI-NH and CSDD total scores in week 16 before, but not after, controlling for multiple testing. There were no significant effects on other subscales. In conclusion, the findings in paper 1 suggest that illumination in dementia units is inadequate compared to thresholds suggested for NIF effects of light. However, the results of the DEM.LIGHT trial, which increased the indoor illumination in dementia units, were mixed. Based on our results, we cannot make clear recommendations regarding the use of ambient BLT in dementia units. Several methodological challenges and sample characteristics may limit the generalisability of these results.Doktorgradsavhandlin

ENIGMA-Sleep:Challenges, opportunities, and the road map

Neuroimaging and genetics studies have advanced our understanding of the neurobiology of sleep and its disorders. However, individual studies usually have limitations to identifying consistent and reproducible effects, including modest sample sizes, heterogeneous clinical characteristics and varied methodologies. These issues call for a large-scale multi-centre effort in sleep research, in order to increase the number of samples, and harmonize the methods of data collection, preprocessing and analysis using pre-registered well-established protocols. The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium provides a powerful collaborative framework for combining datasets across individual sites. Recently, we have launched the ENIGMA-Sleep working group with the collaboration of several institutes from 15 countries to perform large-scale worldwide neuroimaging and genetics studies for better understanding the neurobiology of impaired sleep quality in population-based healthy individuals, the neural consequences of sleep deprivation, pathophysiology of sleep disorders, as well as neural correlates of sleep disturbances across various neuropsychiatric disorders. In this introductory review, we describe the details of our currently available datasets and our ongoing projects in the ENIGMA-Sleep group, and discuss both the potential challenges and opportunities of a collaborative initiative in sleep medicine

Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: A randomised clinical trial protocol

Introduction Major depression is a highly prevalent pathology that is currently the second most common cause of disease-induced disability in our society. The onset and continuation of depression may be related to a wide variety of biological and psychosocial factors, many of which are linked to different lifestyle aspects. Therefore, health systems must design and implement health promotion and lifestyle modification programmes (LMPs), taking into account personal factors and facilitators. The main objective of this protocol is to analyse the clinical effectiveness, cost-effectiveness and cost utility of an LMP and an LMP with information and communication technologies (ICTs) as adjunctive treatment for depression in primary care patients. The secondary objectives are to analyse the clinical effectiveness in the subgroup that presents comorbidity and to analyse the correlation between personal factors on health behaviour and lifestyle patterns. Methods and analysis A randomised, multicenter pragmatic clinical trial with three parallel groups consisting of primary healthcare patients suffering from subclinical, mild or moderate depression. The following interventions will be used: (1) Usual antidepressant treatment with psychological advice and/or psychotropic drugs prescribed by the general practitioner (treatment as usual (TAU)). (2) TAU+LMP. A programme to be imparted in six weekly 90-minute group sessions, intended to improve the following aspects: behavioural activation+daily physical activity+adherence to the Mediterranean diet pattern+sleep hygiene+careful exposure to sunlight. (3) TAU+LMP+ICTs: healthy lifestyle recommendations (TAU+LMP)+monitoring using ICTs (a wearable smartwatch). The primary outcome will be the depressive symptomatology and the secondary outcomes will be the quality of life, the use of health and social resources, personal factors on health behaviour, social support, lifestyle patterns and chronic comorbid pathology. Data will be collected before and after the intervention, with 6-month and 12-month follow-ups. Ethics and dissemination This study has been approved by the Clinical Research Ethics Committee of Aragón (approval number: C.P.-C.I. PI18/286) and the Research Ethics Committee of the Balearic Islands (IB3950/19 PI). Data distribution will be anonymous. Results will be disseminated via conferences and papers published in peer-reviewed, open-access journals. Trial registration number ClinicalTrials.gov Registry (NCT03951350)

Blue-blocking glasses as adjunctive treatment for bipolar mania - and exploration of motor activity patterns in serious mental disorders

Background: There is a need for more effective treatments of bipolar mania. Promising reports of the effects of dark therapy on bipolar disorder symptoms and the discovery of a mainly blue-light sensitive daylight-signaling retinal ganglion cells has resulted in the utility of BB glasses to create a virtual darkness condition for the brain. Changes in activation or aberrant motor activity is present in all serious mental disorders. Actigraphy is a non-invasive and simple means of assessing motor activity, but is still mostly used to assess sleep outcomes. Before the utility of actigraphy can be broadened, there is need for further exploration of daily activity pattern characteristics for the diagnostic entities. Aims: By means of the Virtual Darkness as Additive Treatment in Mania (VATMAN) trial, we aimed to test the effectiveness and feasibility of BB glasses as an adjunctive treatment for mania compared to placebo glasses. As part of the Agitation at Admittance to a Psychiatric Acute Department Study, we aimed to characterize the motor activity patterns among a new sample of patients with psychotic disorders, and compare these characteristics to the motor activity patterns of patients with affective disorders and with healthy controls. Methods: Eligible patients for the VATMAN trial (hospitalized with bipolar disorder mania and otherwise fulfilling inclusion criteria) were randomized to receive either BB-glasses or clear-lensed placebo glasses. The glasses were worn as an adjunctive treatment from 6:00 p.m. to 8:00 a.m. for seven consecutive days. Manic symptoms were rated daily using the Young Mania Rating Scale. Motor activity was measured using wrist-worn actigraphs. Feasibility was assessed using a self-report patient experience questionnaire together with the clinical observation of side-effects. Sleep was assessed using actigraphy-derived sleep parameters. In the Agitation at Admittance to a Psychiatric Acute Department study, all hospitalized patients in the acute psychiatric ward in Østmarka Hospital, Trondheim were asked to wear an actigraph for 24 h. The motor activity patterns of patients diagnosed with schizophrenia and other psychotic disorders were compared to those of patients with mania, motor-retarded unipolar depression, and healthy controls. Linear and non-linear analytical methods were used to describe and compare motor activity variability and complexity (irregularity) for a 24 h period as well as in morning and evening sequences. Results: Out of 32 randomized patients in the VATMAN trial, 12 patients in the BB-group and 11 patients in the placebo-group were included in the analyses. After seven days, the Cohen’s d effect size was 1.86. There was a significant group difference in YMRS scores after three days (p = 0.042) and the group difference increased steadily throughout the intervention. Observed side effects included headache in one patient and rapidly reversible depressive symptoms in two patients. Actigraphy-derived sleep outcomes at night five showed significantly higher sleep efficiency, lower motor activity and less minutes of wake after sleep onset in the BB group as compared to the placebo group. Several patients in both groups displayed a 48 h-like rhythm of shorter or disrupted sleep. The schizophrenia spectrum group shared the characteristic of high motor activity variability with the unipolar depressed group, but differed with respect to more irregular (complex) activity pattern in the morning sequence. The schizophrenia spectrum and the mania groups could not be separated using formal statistical analyses, being most similar with regards to high morning activity irregularity. The mania group was the only one to show a blunted morning-to-evening activity fluctuation, while the normal morning-to-evening decline was more preserved in the schizophrenia spectrum group. Conclusions: BB-glasses were found to be both effective and feasible as an adjunctive treatment for mania. The BB-group showed actigraphy-derived sleep parameters reflecting less activated sleep compared with the placebo-group. The use of actigraphy data to characterize diurnal motor activity patterns, by use of the combination of linear and non-linear analytical approaches, seems to have potential for assessment of symptoms and for diagnostic support

Investigation Into the Physical Environmental Correlates of Aggressive Behaviour in Children with Neurodevelopmental Disorders (NDDs)

Background: Physical environmental influences on childhood aggression in children with neurodevelopmental disabilities is a severely under-researched research locus. The aim of this doctorate was to elucidate specific associations between children’s developmental environment and aggressive behaviours, using this evidence to reciprocally inform an experimental psychology project to investigate underlying mechanisms. To explore these effects, the programme of study was broadly divided into three reflexive workstreams using diverse research methodologies. Methods: In the first workstream, I conducted a systematic review of the current literature examining physical environmental influences on childhood aggressive behaviours in both typically developing children (aged 0 – 18) and those diagnosed with NDDs. The literature on children with NDDs was substantially limited in comparison to peers without NDDs. The second workstream was comprised of a large-scale secondary data analysis (multiply imputed growth curve modelling) to investigate environmental influences on conduct problems across early development. I used data from the Millennium Cohort Study (MCS) to assess how physical environmental metrics, such as neighbourhood greenspace, air pollution, household crowding, and presence of home damp influenced the development and severity of conduct problems in children with (n=8013) and without NDDs (n=155) between the ages of 3 – 11 years. Finally, building upon evidence from the previous two workstreams, I designed a proof-of-principle psychological experiment to examine the influence of urban nature exposure on children with NDDs. Specifically, simulating a real-world urban greenspace using a Person-Environment-Activity Research Laboratory (PEARL). This facilitated the ability to manipulate and isolate individual environmental aspects of urban nature exposure (light, sound, and projection). Following ethical review and approval, I recruited 3 children (100% male) with mild and moderate intellectual disability aged between 12 – 15 years (Mean age = 14) attending a local school for children with special educational needs. We examined their physiological reactions to four simulated urban green space aspects (light, sound, landscape projections, and vegetation) against a baseline control condition. I also collected demographic information on parent reported aggressive behaviours, exposure to local greenspace(s), physical and mental health history, medication, and adaptive behaviours (ABAS-3). This research lays the foundation for future large scale experimental paradigms that can disentangle the effects of nature exposure in these children, with the aim of translating these findings into real world therapeutic design interventions and relevant policy changes to improve the quality of the built environment for these children. Findings: From articles retrieved from my systematic review I found evidence for the beneficial influences of nature in both populations, and simultaneously negative effects of both noise and air pollution in typically developing children only. Evidence for other environmental aspects such as crowding, music, urbanicity, meteorology, and interior design had either insufficient or inconsistent evidence to extrapolate concreate conclusions. More evidence on the effect of these exposures on child aggression outcomes is recommended. From the analysis of the MCS cohort I found various sociodemographic factors (ethnicity, sex, poverty, family structure, maternal distress) and internal residential conditions were associated with increased childhood conduct problem trajectories in both groups of children. I also discovered potential evidence of a moderating influence effect of intellectual disability on the relationship between spatial density and conduct problems. From the final experimental project, I report preliminary evidence for the influence of urban greenspaces to reduce physiological arousal in children with complex neurodisability profiles. Initial evidence for the hierarchical nature of urban greenspace sensorial aspects was reported, for example: that urban nature soundscapes maybe a more influential environmental stimuli than lighting or landscape projections. Conclusion: Drawing together multi-disciplinary research methodologies facilitated the ability to identify disparities in research examining physical environmental determinants of aggression in neurodiverse child populations. Reciprocally, the systematic review and secondary data analysis contributed incrementally to filling this lacuna of research. Using findings from these two work streams, I identified that exploring the potentially therapeutic influences of urban nature exposure on children with neurodevelopmental disorders may provide novel indicators of its aetiological mechanisms. I reported original findings supporting these research aims, elucidating the potential hierarchical nature of urban greenspace elements. This was also the first study of its kind reporting the potential for simulated urban park spaces to reduce physiological arousal in neurodivergent children with aggressive behavioural difficulties